Apparently the powers that be in the UK have decided to shell out the money to build two (small) proton beam radiation therapy (PBRT) units in the UK — one in London and one in Manchester. The media coverage suggests that they will be used primarily for the treatment of rare cancers in children. The centers are scheduled to come on line in 2017. … READ MORE …
Filed under: Management, Treatment | Tagged: cost, PBRT, proton beam, UK | 1 Comment »
In an utterly unsurprising announcement from the UK, the National Institute for Clincial Excellence (NICE) has issued draft guidance in which it refuses to cover the proposed cost of abiraterone actetate. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: abiraterone, cost, NICE, UK, Zytiga | 6 Comments »
In the United Kingdom (UK), the National Institute for Health and Clinical Excellence (NICE) has issued initial (draft) guidance that recommends against coverage of the costs of second-line chemotherapy with cabazitaxel (Jevtana®) and prednisone (or prednisolone). … READ MORE …
Filed under: Management, Treatment | Tagged: cabazitaxel, NICE, UK | 3 Comments »
According to a report in today’s Daily Telegraph, the UK’s National Institute for Health and Clinical Excellence (NICE) has determined that “cabazitaxel would not be a cost effective use of limited NHS resources” for the treatment of men with metastatic, castration-resistant prostate cancer (mCRPC). … READ MORE …
Filed under: Management, Treatment | Tagged: abiraterone, cabazitaxel, cost, NICE, UK | 2 Comments »
This month’s issue of The ASCO Post includes an interview with Dr. Chris Parker, a prostate cancer specialist at the Academic Urology Unit, The Royal Marsden NHS Foundation Trust (one of the UK’s most prestigious prostate cancer units), about the realities of oncology services in general and prostate cancer services in particular in the United Kingdom. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management | Tagged: National Health Service, NHS, UK | 14 Comments »
As a follow-up to our earlier post on this topic, we have now identified the original media release issued by Kings College London and the UK’s National National Cancer Intelligence Network (NCIN) on which today’s article in The Daily Telegraph (and other media) was based. That article clearly stated that up to 49 percent of men diagnosed with prostate cancer were dying from this disorder. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: mortality, prostate cancer-specific, UK, United Kingdom | 11 Comments »
A report in The Daily Telegraph today states that “experts at King’s College London have now found the proportion of men with prostate cancer who actually die from it to be higher than previously thought.” Supposedly, the new research finding is that for 49 percent of 20,000 men diagnosed between 1997 and 2007 “prostate cancer was the principal cause of death.” … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: mortality, prostate cancer-specific, UK, United Kingdom | 7 Comments »
A recently published study reports on the incidence of PSA testing in the United Kingdom (UK) in 2007. There is no national recommendation for prostate cancer testing (i.e., “screening”) in the UK. However, PSA testing is covered by National Health Service; men who request a PSA test will normally be given one by their family doctor. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: risk, screening, testing, UK | 1 Comment »
Although there is no information (as yet) on the web site of the UK’s National Screening Committee (NSC), a BBC News report has stated that the NSC has “recommended against a screening programme for prostate cancer, saying its potential harms would outweigh any benefits.” … READ MORE …
Filed under: Diagnosis, Risk | Tagged: PSA, risk, screening, testing, UK | 4 Comments »
According to a poll commissioned by the Prostate Cancer Charity in the UK, 20 percent of British men who meet “at-risk” age criteria and who ask their family doctor for a PSA test have their request turned down. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: awareness, risk, UK | 2 Comments »
The Prostate Testing for Cancer and Treatment (ProtecT) trial is being implemented in the UK to evaluate outcomes of three different types of treatment: surgery, radiation, and “active monitoring” in the management of localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: incidence, ProtecT, risk, screening, UK | Leave a comment »
Reports in the British media state that the UK’s Ministry of Health is committing to the broader availability of proton beam radiation therapy (PBRT) through the British National Health Service (NHS). … READ MORE …
Filed under: Management, Treatment | Tagged: PBRT, proton beam radiation therapy, UK | 4 Comments »
Over the past couple of years, Baker and colleagues at the University of Leicester in England have developed and “operationalized” what appears to be a relatively sophisticated survey system to rate patient and spouse/partner/caregiver experiences from initial assessment of risk for prostate cancer through post-treatment follow-up. The “New” Prostate Cancer InfoLink thinks that a similar survey might be useful in the USA and other countries! … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: patient experience, quality of care, survey, UK | Leave a comment »
The UK prostate cancer advocacy community appears to have scored a major “hit” with an article in the MailOnline on Monday entitled, “What EVERY man (and his wife) should know about prostate cancer.” If you have a spare 3 minutes, The “New” Prostate Cancer InfoLink suggests you leave a brief comment at the bottom of this article on thne MailOnline web site, congratulating the MailOnline for publishing this article. This is exactly the sort of regular media coverage that is needed to expand prostate cancer awareness among the general public in every nation.
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: advocacy, awareness, UK | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 